Compare Compass Inc. Class A Common Stock (COMP) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 3.6× Compass Inc. Class A Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Compass Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| COMP | RPRX | |
|---|---|---|
Market Cap | $7.05B | $25.27B |
Volume | 15,310,192 | 3,671,183 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $63.96 |
52-Week Low | $6.68 | $35.44 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
